Why Is Morgan Stanley Raising Target Price on Apollo Hospitals?
About Apollo Hospitals
Apollo Hospitals remains one of India’s leading integrated healthcare providers with strong presence across hospitals, diagnostics, pharmacies, and digital healthcare platforms.
The company has continued expanding its hospital capacity while also strengthening its digital healthcare ecosystem through Apollo 24/7 and Apollo HealthCo.
Morgan Stanley View on Apollo Hospitals
🔹 Morgan Stanley maintained “Overweight” rating.
🔹 Target price raised to ₹9,397 from ₹8,833.
🔹 Q4 EBITDA exceeded estimates by nearly 7%.
🔹 Revenue growth driven by hospitals and Apollo HealthCo businesses.
🔹 Brokerage expects digital operating leverage to improve margins.
🔹 Apollo 24/7 likely to achieve breakeven by Q1–Q2 FY27.
🔹 New hospital clusters expected to break even by FY28.
Healthcare-sector investors are also closely tracking Nifty Trading Signals as hospital and healthcare stocks continue witnessing institutional interest.
Q4FY26 Performance Snapshot
| Metric | Observation |
|---|---|
| Revenue Growth | 18% YoY |
| EBITDA Margin | 15.3% |
| Apollo 24/7 | Breakeven expected by FY27 |
| Hospital Expansion | New clusters to break even by FY28 |
Growth Drivers Highlighted by Morgan Stanley
|
Operational Strengths 🔹 Strong hospital occupancy trends 🔹 HealthCo growth accelerating 🔹 Improving EBITDA performance 🔹 Strong digital healthcare ecosystem |
Future Triggers 🔹 Apollo 24/7 breakeven milestone 🔹 Margin expansion from digital leverage 🔹 New hospital cluster stabilization 🔹 Continued premium healthcare demand |
Morgan Stanley expects Apollo Hospitals to deliver strong long-term earnings growth supported by expansion in hospitals, digital healthcare, diagnostics, and pharmacy businesses.
Morgan Stanley FY26–FY28 Estimates
|
Revenue CAGR 16% |
EBITDA CAGR 19% |
PAT CAGR 30% |
Hospital-sector traders are also monitoring BankNifty Option Trends as healthcare and consumption-focused sectors continue attracting institutional buying interest.
What Investors May Watch Ahead
🔹 Occupancy growth across new hospitals
🔹 Apollo 24/7 profitability timeline
🔹 Margin expansion sustainability
🔹 Expansion in diagnostics and pharmacy businesses
🔹 Healthcare demand trends amid rising premiumisation
Investor Takeaway: Derivative Pro & Nifty Expert Gulshan Khera, CFP® believes Apollo Hospitals continues strengthening its position through hospital expansion, improving digital operating leverage, and strong healthcare demand trends. Brokerages remain optimistic on long-term earnings growth as new hospital clusters mature and Apollo 24/7 approaches breakeven. Readers can continue following broader market insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Related Queries on Apollo Hospitals
Why Did Morgan Stanley Raise Apollo Hospitals Target Price?
How Is Apollo 24/7 Performing?
What Is Driving Apollo Hospitals Revenue Growth?
Why Healthcare Stocks Remain in Focus?
Can Apollo Hospitals Improve Margins Further?
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
